Exeter, Devon UK • [date-today] • VOL XII
Home Uncategorized Can Stem Cell Therapy Repair the Alzheimer’s Brain? 

Can Stem Cell Therapy Repair the Alzheimer’s Brain? 

James Wiszniewski explores how stem cell therapy could offer a new approach for treating Alzheimer's.
3 mins read
Written by

New research has suggested stem cell therapy could offer a promising approach to treating Alzheimer’s, with clinical trial results providing the possibility of protecting the brain from damage rather than simply slowing memory loss. 

In a landmark 2009 experiment, researchers transplanted 100,000 neural stem cells into the hippocampus (the brain region responsible for learning and memory) of mice with an Alzheimer’s-like disease. Within a month, the mice performed significantly better in memory tests with a 67% increase in connections between brain cells. 

Most strikingly, these improvements occurred despite no reduction in the abnormal proteins associated with Alzheimer’s, suggesting stem cells could improve brain function without removing the underlying damage. 

Researchers found that the transplanted cells increased levels of BDNF, a protein that helps brain cells survive and strengthen their connections. When researchers reduced BDNF production, the improvements in memory disappeared, suggesting that stem cells were helping surviving brain cells communicate more effectively, rather than reversing the disease itself.

The brain region responsible for learning and memory- of mice with an Alzheimer’s-like disease

A different approach to treating Alzheimer’s 

Alzheimer’s is a progressive brain disease that damaged and eventually kills nerve cells. As this damage builds up, it causes worsening problems with memory, thinking and behaviour- symptoms collectively described as dementia. Alzheimer’s is the most common cause of dementia, accounting for 60- 80% of cases worldwide.  

Current treatments, including lecanemab, target the build-up of amyloid-beta, one of the two major abnormal proteins associated with Alzheimer’s, along with tau. Amyloid-beta is an important target, but it is not necessarily the single most important cause of the disease. Although treatments that can remove amyloid-beta can modestly slow cognitive decline, they cannot replace brain cells or connections that have already been lost. 

Stem cell therapy could offer a different approach. Stem cells can both reproduce themselves and develop into more specialised cell types. Researchers are investigating whether introducing these cells into the damaged brain could help protect surviving neurons, reduce harmful inflammation and potentially replace some damaged cells. 

Neural stem cells are one possibility, but another type, known as mesenchymal stem cells, has also attracted attention. Experiments in mice have shown that mesenchymal stem cells can reduce brain inflammation and the build-up of harmful proteins, while improving learning and memory. Thus, these stem cells can help the brain continue functioning even after Alzheimer’s has already caused damage, rather than only slowing further decline, encouraging results from human trials.

More recently, researchers have begun testing whether these findings could translate into treatments for people. A 2025 clinical trial involving 49 people with mild Alzheimer’s investigated mesenchymal stem cells taken from donated bone marrow. 

After 39 weeks, brain scans showed approximately 48% less overall brain shrinkage and 62% less shrinkage in the left hippocampus among patients receiving the treatment compared with those given a placebo trial. Some measures of memory, thinking and everyday functioning also showed rather encouraging improvements, though this is yet to be substantiated. Most importantly, the treatment met the trial’s main safety target. 

These findings are particularly significant because they suggest stem cell therapy could help protect the brain against the physical deterioration associated with Alzheimer’s. 

However, the treatment remains experimental. The trial involved relatively few participants and lasted just 39 weeks, meaning larger studies are needed to establish whether the benefits are long-lasting and whether the treatment is safe over time. 

Nevertheless, the discoveries mark an encouraging development in Alzheimer’s research. While existing treatments largely focus on slowing the disease, stem cell therapy could open up the possibility of protecting the brain and preserving the connections that allow it to function. 

You may also like

Subscribe to our newsletter

Sign Up for Our Newsletter